Intravenous Olanzapine for Acute Agitation in the Emergency Department

Journal of Pharmacy Practice and Research

Volumn 41, Issue 2, 2011, Pages 135-137

  Chan, Esther W ^a   Knott, Jonathan C ^b   Taylor, David McD ^c   Kong, David C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b MELBOURNE HEALTH   (Australia)

^c Emergency Department Austin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DROPERIDOL; HALOPERIDOL; MIDAZOLAM; OLANZAPINE; RISPERIDONE;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; ADULT; AEROSOL; ARTICLE; CASE REPORT; COFFEE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEMALE; GENERAL PRACTITIONER; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL HISTORY; MEDICAL STAFF; PARANOIA; PATIENT COMPLIANCE; PATIENT REFERRAL; PEPPER; POLICE; RELAPSE; RESTLESSNESS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEDATION; VIOLENCE; WANDERING BEHAVIOR;

EID: 79960351624     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2011.tb00681.x     Document Type: Article

References (26)

1. Hill S, Petit J. The violent patient. Emerg Med Clin North Am 2000; 18: 301-15.
2. Knott JC, Bennett D, Rawet J, Taylor DM. Epidemiology of unarmed threats in the emergency department. Emerg Med Australas 2005; 17: 351-8.
3. Allen MH. Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry 2000; 61 (suppl 14): 11-20.
4. Cannon ME, Sprivulis P, McCarthy J. Restraint practices in Australasian emergency departments. Aust N Z J Psychiatry 2001; 35: 464-7.
5. Wagstaff AJ, Easton J, Scott LJ. Intramuscular olanzapine: a review of its use in the management of acute agitation. CNS Drugs 2005; 19: 147-64.
6. Czekalla J, Kollack-Walker S, Beasley C. Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics. J Clin Psychiatry 2001; 62 (suppl 2): 35-40.
7. Chan EW, Knott JC, Taylor DMD, Phillips GA, Kong DC. Intravenous olanzapine-another option for the acutely agitated patient? Emerg Med Australas 2009; 21: 241-2.
8. MIMS Online. Olanzapine; antipsychotic agents. St Leonards: MIMS Australia; 2011.
9. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP; Expert Consensus Panel for Behavioral Emergencies 2005. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005; 11 (suppl 1): 5-108.
10. Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, et al. A doubleblind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 2001; 21: 389-97.
11. Damsa C, Adam E, De Gregorio F, Cailhol L, Lejeune J, Lazignac C, et al. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room. Gen Hosp Psychiatry 2007; 29: 51-3.
12. Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med 2003; 21: 192-8.
13. Raveendran NS, Tharyan P, Alexander J, Adams CE; TREC-India II Collaborative Group. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 2007; 335: 865.
14. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al. A Double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002; 59: 441-8.
15. Tulloch KJ, Zed PJ. Intramuscular olanzapine in the management of acute agitation. Ann Pharmacother 2004; 38: 2128-35.
16. Belgamwar RB, Fenton M. Olanzapine IM or velotab for acutely disturbed/ agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev 2005; Issue 2. Art. No.: CD003729. Doi:10.1002/14651858.CD0037 29.pub2.
17. Chan EW, Taylor DMD, Knott JC, Kong DC. Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments. Emerg Med Australas 2011; 23: 23-32.
18. Wilson M, Macdonald K, Vilke G, Feifel D. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. J Emerg Med 2010. In press.
19. Parenterals. In: Walter Lund, editor. The Pharmaceutical codex. Principles and practice of pharmaceutics. 12th ed. London: The Pharmaceutical Press; 1994. p. 98.
20. Duma RJ, Akers MJ, Turco SJ. Parenteral drug administration: routes, precautions, problems, complications, and drug delivery systems. In: Avis KE, Lieberman HA, Lachman L, editors. Pharmaceutical dosage forms: parenteral medications. Volume 1. 2nd ed. New York: Marcel Dekker; 1992. p. 20.
21. National Prescribing Service. Rational assessment of drugs and research: olanzapine depot injection (Zyprexa Relprevv) for schizophrenia. Surry Hills: National Prescribing Service; 2009. Available from .
22. Detke H, McDonnell D, Brunner E, Zhao F, Sorsaburu S, Stefaniak V, et al. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases. BMC Psychiatry 2010; 10: 43.
23. MIMS Online. Olanzapine, Zyprexa Relprevv; antipsychotic agents. MIMS Australia; 2011.
24. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003; 20: 339-46.
25. Silva E. Rapid tranquillisation in isolated units, i.m. medication preferable to i.v. J Psychopharmacol 1999; 13: 200-2.
26. Knott JC, Isbister GK. Sedation of agitated patients in the emergency department. Emerg Med Australas 2008; 20: 97-100.